SEC Insider Transactions from Jenne Kyle.

Last updated: 2026-03-14 11:57 UTC | Total transactions: 19

Jenne Kyle, EVP and Chief Global Product Strategy Officer at Ionis Pharmaceuticals ($IONS), sold about $3.1 million in company shares across four open market transactions in the past year. Her latest sale occurred on March 10, 2026. These sales rank her 2,687th among 11,678 insiders by total value, trailing the average of $8.6 million over 6.4 transactions. She reported no open market purchases during this period.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
March 10, 2026 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr M Common Stock 32602 $46.10 48,991.0000 158,964,772 198.93% 0.02%
March 10, 2026 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr M Non-Qualified Stock Option (right to buy) 32602 $0.00 32,601.0000 158,964,772 50.00% 0.02%
March 10, 2026 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr M Non-Qualified Stock Option (right to buy) 4675 $0.00 14,025.0000 158,964,772 25.00% 0.00%
March 10, 2026 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr M Common Stock 4675 $34.69 16,389.0000 158,964,772 39.91% 0.00%
March 10, 2026 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr S Common Stock 16086 $76.30 11,714.0000 158,964,772 57.86% 0.01%
March 10, 2026 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr S Common Stock 21191 $75.50 27,800.0000 158,964,772 43.25% 0.01%
Jan. 16, 2026 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr S Common Stock 1823 $75.96 16,389.0000 158,964,772 10.01% 0.00%
Jan. 15, 2026 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr M Common Stock 7013 $0.00 18,212.0000 158,964,772 62.62% 0.00%
Jan. 15, 2026 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr A Performance Restricted Stock Units 25800 $0.00 44,500.0000 158,964,772 137.97% 0.02%
Jan. 15, 2026 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr A Restricted Stock Unit 9675 $0.00 37,725.0000 158,964,772 34.49% 0.01%
Jan. 15, 2026 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr M Restricted Stock Unit 7013 $0.00 29,664.0000 158,964,772 19.12% 0.00%
Jan. 2, 2026 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr A Non-Qualified Stock Option (right to buy) 19350 $0.00 19,350.0000 158,964,772 9999.99% 0.01%
April 16, 2025 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr S Common Stock 3016 $28.36 11,199.0000 158,964,772 21.22% 0.00%
April 15, 2025 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr M Restricted Stock Unit 12226 $0.00 36,677.0000 158,964,772 25.00% 0.01%
April 15, 2025 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr M Common Stock 12226 $0.00 14,215.0000 158,964,772 614.68% 0.01%
Jan. 15, 2025 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr A Restricted Stock Unit 28050 $0.00 28,050.0000 0 9999.99% 0.00%
Jan. 15, 2025 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr A Performance Restricted Stock Units 18700 $0.00 18,700.0000 0 9999.99% 0.00%
Jan. 2, 2025 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr A Non-Qualified Stock Option (right to buy) 18700 $0.00 18,700.0000 0 9999.99% 0.00%
Feb. 26, 2024 IONIS PHARMACEUTICALS INC $IONS Jenne Kyle EVP, Chf GL Pdt Str Ofcr A Non-Qualified Stock Option (right to buy) 65203 $0.00 65,203.0000 0 9999.99% 0.00%